Im Cannabis Corp (IMCC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Im Cannabis Corp (IMCC) has a cash flow conversion efficiency ratio of -1.169x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.22 Million) by net assets ($-3.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Im Cannabis Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Im Cannabis Corp - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Im Cannabis Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Im Cannabis Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Im Cannabis Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Antarctica Limited
NSE:ANTGRAPHIC
|
-0.337x |
|
Aminex PLC
LSE:AEX
|
-0.032x |
|
Fuse Cobalt Inc
V:FUSE
|
-0.057x |
|
GCP Asset Backed Income Fund Limited
LSE:GABI
|
0.107x |
|
Steakholder Foods Ltd
NASDAQ:STKH
|
-0.320x |
|
Polledo S.A.
BA:POLL
|
0.130x |
|
India Capital Growth Fund
LSE:IGC
|
-0.009x |
|
Tijaria Polypipes Limited
NSE:TIJARIA
|
-0.154x |
Annual Cash Flow Conversion Efficiency for Im Cannabis Corp (2003–2025)
The table below shows the annual cash flow conversion efficiency of Im Cannabis Corp from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Im Cannabis Corp market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-3.62 Million | $4.72 Million | -1.305x | -281.07% |
| 2024-12-31 | $3.15 Million | $-1.08 Million | -0.342x | +41.92% |
| 2023-12-31 | $13.70 Million | $-8.07 Million | -0.589x | -10.97% |
| 2022-12-31 | $23.80 Million | $-12.64 Million | -0.531x | -216.71% |
| 2021-12-31 | $204.94 Million | $-34.37 Million | -0.168x | +73.29% |
| 2020-12-31 | $12.61 Million | $-7.92 Million | -0.628x | -175.15% |
| 2019-12-31 | $26.11 Million | $-5.96 Million | -0.228x | -111.37% |
| 2018-12-31 | $-214.65K | $-431.00K | 2.008x | +274.73% |
| 2017-12-31 | $-456.84K | $525.00K | -1.149x | -- |
| 2016-12-31 | $-431.87K | $0.00 | 0.000x | -- |
| 2015-12-31 | $-416.12K | $-26.60K | 0.064x | -88.49% |
| 2014-12-31 | $-370.51K | $-205.70K | 0.555x | +96.27% |
| 2013-12-31 | $-293.01K | $-82.88K | 0.283x | -79.52% |
| 2012-12-31 | $-158.34K | $-218.72K | 1.381x | +3103.63% |
| 2011-12-31 | $9.44 Million | $-434.09K | -0.046x | +31.86% |
| 2010-12-31 | $9.37 Million | $-632.56K | -0.067x | -15.31% |
| 2009-12-31 | $9.02 Million | $-527.85K | -0.059x | +68.24% |
| 2008-12-31 | $6.36 Million | $-1.17 Million | -0.184x | -1.44% |
| 2007-12-31 | $2.39 Million | $-433.97K | -0.182x | +31.98% |
| 2006-12-31 | $1.45 Million | $-386.29K | -0.267x | +24.58% |
| 2005-12-31 | $819.27K | $-290.10K | -0.354x | -14.79% |
| 2004-12-31 | $1.02 Million | $-313.91K | -0.308x | +17.85% |
| 2003-12-31 | $772.97K | $-290.23K | -0.375x | -- |
About Im Cannabis Corp
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.